Is HER2 a protein or a gene and guess which cancer got HER2?

[ginfreely]

 

[ginfreely]

 

[ginfreely]

 

[lostvirgin]

Oh dear, why are you posting this nonsense? Nobody is interested

 

[ginfreely]

Oh dear, why are you posting this nonsense? Nobody is interested

Who cares whether you dogs are interested? Fuck off

 

[ginfreely]

FDA Amends Approval of Pembrolizumab to Treat Stomach and Esophageal Junction Cancer​

Subscribe
November 17, 2023, by Carmen Phillips

Treatment for HER2-positive stomach and gastroesophageal junction cancers is expected to change based on an update to the Food and Drug Administration's 2021 accelerated approval of pembrolizumab (Keytruda) for these cancers.
Credit: iStock

https://www.cancer.gov/news-events/...da-pembrolizumab-stomach-esophageal-her2-pdl1

 

[ginfreely]

https://www.drugs.com/history/keytruda.html

Keytruda (pembrolizumab) is a human PD-1 (programmed death receptor-1)-blocking antibody indicated for the treatment of melanoma, non-small cell lung cancer, head and neck squamous cell carcinoma, classical Hodgkin lymphoma, primary mediastinal large B-cell lymphoma, urothelial carcinoma, microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR) cancer, microsatellite instability-high or mismatch repair deficient colorectal cancer, gastric cancer, esophageal cancer, cervical cancer, hepatocellular carcinoma, biliary tract cancer, Merkel cell carcinoma, renal cell carcinoma, endometrial carcinoma, tumor mutational burden-high (TMB-H) cancer, cutaneous squamous cell carcinoma, and triple-negative breast cancer.

 

[ginfreely]

 

[lostvirgin]

Who cares whether you dogs are interested? Fuck off

Oh dear, what an uncultured bitch.
I hope you get all the diseases you posted, live and suffer till you are 100 years old.

 

[ginfreely]

View attachment 194773

Conclusion​

For NSCLC patients with TPS≥50%, the ICER in the base-case for pembrolizumab as 1st-line treatment is $155,630 – which is between 2-3x gross domestic product (GDP) per capita of Singapore (S$73,167) in 2016, whereas the estimated ICER with Pembrolizumab PAP is 1-2x GDP per capita. Depending on threshold boundaries adopted, 1st line pembrolizumab for patients with similar profile (TPS ≥50%) as those in KN024, would be a cost-effective treatment compared to SoC in Singapore.

 

[ginfreely]

Oh dear, what an uncultured bitch.
I hope you get all the diseases you posted, live and suffer till you are 100 years old.

bitch is your Cantonese whore mother that open leg gave birth no teach raised bully dogs that hide in rat hole insult and bully woman as slut whore mistress Pui !

 

[ginfreely]

Conclusion​

For NSCLC patients with TPS≥50%, the ICER in the base-case for pembrolizumab as 1st-line treatment is $155,630 – which is between 2-3x gross domestic product (GDP) per capita of Singapore (S$73,167) in 2016, whereas the estimated ICER with Pembrolizumab PAP is 1-2x GDP per capita. Depending on threshold boundaries adopted, 1st line pembrolizumab for patients with similar profile (TPS ≥50%) as those in KN024, would be a cost-effective treatment compared to SoC in Singapore.

Every drug is expensive in Singapore and no need to treat. I bet mudland healthcare is better on such drugs. Even cpac they can cover.

 

[lostvirgin]

How's your vagina doing?

 

[Balls2U]

View attachment 194764

This is your elixir of health. Drink a glass every night and you won't get any cancer or tumour.

 

[Cottonmouth]

Your cheebye got cancer? Cut off the whole fucking piece and burn the rest of you!

Your urn will be passed around in little India to be filled with sperm and curry. You filthy slut.

 

[Cottonmouth]

I want to pour some boiling oil on your cheebye then fuck you with a knife repeatedly. You disgusting cunt. @ginfreely.